Kurosaki, T.; Kanda, H.; Hashizume, J.; Sato, K.; Harasawa, H.; Nakamura, T.; Sasaki, H.; Kodama, Y.
Delivery of pDNA to the Lung by Lipopolyplexes Using N-Lauroylsarcosine and Effect on the Pulmonary Fibrosis. Pharmaceutics 2021, 13, 1983.
https://doi.org/10.3390/pharmaceutics13111983
AMA Style
Kurosaki T, Kanda H, Hashizume J, Sato K, Harasawa H, Nakamura T, Sasaki H, Kodama Y.
Delivery of pDNA to the Lung by Lipopolyplexes Using N-Lauroylsarcosine and Effect on the Pulmonary Fibrosis. Pharmaceutics. 2021; 13(11):1983.
https://doi.org/10.3390/pharmaceutics13111983
Chicago/Turabian Style
Kurosaki, Tomoaki, Hiroki Kanda, Junya Hashizume, Kayoko Sato, Hitomi Harasawa, Tadahiro Nakamura, Hitoshi Sasaki, and Yukinobu Kodama.
2021. "Delivery of pDNA to the Lung by Lipopolyplexes Using N-Lauroylsarcosine and Effect on the Pulmonary Fibrosis" Pharmaceutics 13, no. 11: 1983.
https://doi.org/10.3390/pharmaceutics13111983
APA Style
Kurosaki, T., Kanda, H., Hashizume, J., Sato, K., Harasawa, H., Nakamura, T., Sasaki, H., & Kodama, Y.
(2021). Delivery of pDNA to the Lung by Lipopolyplexes Using N-Lauroylsarcosine and Effect on the Pulmonary Fibrosis. Pharmaceutics, 13(11), 1983.
https://doi.org/10.3390/pharmaceutics13111983